| Opinion Published In: April, 2017 | |
| Are we Satisfactorily Managing Type-2 Diabetes Mellitus Patients? | |
| Munnichoodappa C* | |
| Mini Review Published In: April, 2017 | |
| New Data on Cardiovascular Effects of Glucagon- Like Peptide-1 Receptor Agonists | |
| Anastasios Tentolouris, Ioanna Eleftheriadou and Nikolaos Tentolouris* | |
| Short communication Published In: April, 2017 | |
| Patient Retention Stewardship in Real world Evidence Studies: the Pentad of P’s Model | |
| Amit Kumar1*, Sanjay Kalra2 and Vandna Rana3 | |
| Mini Rewiew Published In: April, 2017 | |
| Diabetic Nephropathy: What is Best Therapeutic Option? | |
| Maryam Zain* | |
| Mini Rewiew Published In: April, 2017 | |
| Is Telomere Shortening a Genetic Factor That Predisposes to Diabetes Mellitus 2 and Oxidative Stress, or do They Induce It? A Telomere Shortening Predisposes to T2DM | |
| Murillo Ortiz Blanca* and Martínez Garza Sandra | |
Open Access by Juniper Publishers is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at www.juniperpublishers.com. 
| Above IE 7.0 version | Privacy Policy
CRDOJ Home
